This is beneficial for the cancer if the protein gets insensitive to upstream-signals and fires constitutively an oncogenic signal as e.g. the ABL-BCR fusion protein in chronic myelogenous leukemia [19]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.